Positive Association of Plasma Trimethylamine-N-Oxide and Atherosclerosis in Patient with Acute Coronary Syndrome
Aim. Atherosclerosis is the major cause of acute coronary syndrome (ACS) which is a significant contributor to both morbidity and mortality in the world. The microbiome-derived metabolite trimethylamine-N-oxide (TMAO) has aroused great interest and controversy as a risk factor of atherosclerosis. Th...
Main Authors: | Wanwen Kong, Junyi Ma, Ying Lin, Weiyu Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi-Wiley
2022-01-01
|
Series: | Cardiovascular Therapeutics |
Online Access: | http://dx.doi.org/10.1155/2022/2484018 |
Similar Items
-
Atherosclerosis and trimethylamine-N-oxide — the gut microbiota potential
by: I. N. Grigorieva
Published: (2022-09-01) -
Gut Metabolite Trimethylamine-N-Oxide in Atherosclerosis: From Mechanism to Therapy
by: BingYu Wang, et al.
Published: (2021-11-01) -
Plasma trimethylamine-N-oxide, its precursors and risk of cardiovascular events in patients with acute coronary syndrome: Mediating effects of renal function
by: Raul Sanchez-Gimenez, et al.
Published: (2022-09-01) -
Trimethylamine Oxidation into the Proatherogenic Trimethylamine N-Oxide Is Higher in Coronary Heart Disease Men: From the CORDIOPREV Study
by: Helena Garcia-Fernandez, et al.
Published: (2025-01-01) -
Plasma Trimethylamine‐N‐Oxide and Incident Ischemic Stroke: The Cardiovascular Health Study and the Multi‐Ethnic Study of Atherosclerosis
by: Rozenn N. Lemaitre, et al.
Published: (2023-08-01)